These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 16156899)
1. Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss. McDonald JM; Dunmire V; Taylor E; Sawaya R; Bruner J; Fuller GN; Aldape K; Zhang W Mol Cancer; 2005 Sep; 4():35. PubMed ID: 16156899 [TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
3. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Mukasa A; Ueki K; Matsumoto S; Tsutsumi S; Nishikawa R; Fujimaki T; Asai A; Kirino T; Aburatani H Oncogene; 2002 Jun; 21(25):3961-8. PubMed ID: 12037678 [TBL] [Abstract][Full Text] [Related]
4. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity. Franco-Hernández C; Martínez-Glez V; de Campos JM; Isla A; Vaquero J; Gutiérrez M; Casartelli C; Rey JA Cancer Genet Cytogenet; 2009 Apr; 190(2):93-6. PubMed ID: 19380026 [TBL] [Abstract][Full Text] [Related]
5. Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors. Prayson RA; Castilla EA; Hartke M; Pettay J; Tubbs RR; Barnett GH Am J Clin Pathol; 2002 Oct; 118(4):512-7. PubMed ID: 12375636 [TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2. Fransson S; Martinsson T; Ejeskär K Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral distribution of 1p loss in oligodendroglial tumors. Kros JM; van der Weiden M; Zheng PP; Hop WC; van den Bent MJ; Kouwenhoven MC J Neuropathol Exp Neurol; 2007 Dec; 66(12):1118-23. PubMed ID: 18090920 [TBL] [Abstract][Full Text] [Related]
9. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Iuchi T; Namba H; Iwadate Y; Shishikura T; Kageyama H; Nakamura Y; Ohira M; Yamaura A; Osato K; Sakiyama S; Nakagawara A Genes Chromosomes Cancer; 2002 Oct; 35(2):170-5. PubMed ID: 12203781 [TBL] [Abstract][Full Text] [Related]
10. Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas. Sanson M; Leuraud P; Marie Y; Delattre JY; Hoang-Xuan K Ann Neurol; 2002 Jul; 52(1):105-7. PubMed ID: 12112056 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles associated with treatment response in oligodendrogliomas. French PJ; Swagemakers SM; Nagel JH; Kouwenhoven MC; Brouwer E; van der Spek P; Luider TM; Kros JM; van den Bent MJ; Sillevis Smitt PA Cancer Res; 2005 Dec; 65(24):11335-44. PubMed ID: 16357140 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. Lavon I; Zrihan D; Zelikovitch B; Fellig Y; Fuchs D; Soffer D; Siegal T Clin Cancer Res; 2007 Mar; 13(5):1429-37. PubMed ID: 17332285 [TBL] [Abstract][Full Text] [Related]
13. ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties. Hubstenberger A; Labourdette G; Baudier J; Rousseau D Exp Cell Res; 2008 Sep; 314(15):2870-83. PubMed ID: 18639545 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Tews B; Roerig P; Hartmann C; Hahn M; Felsberg J; Blaschke B; Sabel M; Kunitz A; Toedt G; Neben K; Benner A; von Deimling A; Reifenberger G; Lichter P Oncogene; 2007 Jul; 26(34):5010-6. PubMed ID: 17311001 [TBL] [Abstract][Full Text] [Related]
15. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Gadji M; Fortin D; Tsanaclis AM; Drouin R Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Scheie D; Andresen PA; Cvancarova M; Bø AS; Helseth E; Skullerud K; Beiske K Am J Surg Pathol; 2006 Jul; 30(7):828-37. PubMed ID: 16819324 [TBL] [Abstract][Full Text] [Related]
17. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors. Husemann K; Wolter M; Büschges R; Boström J; Sabel M; Reifenberger G J Neuropathol Exp Neurol; 1999 Oct; 58(10):1041-50. PubMed ID: 10515227 [TBL] [Abstract][Full Text] [Related]
19. Chromosome 1p loss evaluation in anaplastic oligodendrogliomas. Idbaih A; Kouwenhoven M; Jeuken J; Carpentier C; Gorlia T; Kros JM; French P; Teepen JL; Delattre O; Delattre JY; van den Bent M; Hoang-Xuan K Neuropathology; 2008 Aug; 28(4):440-3. PubMed ID: 18312547 [TBL] [Abstract][Full Text] [Related]
20. Can morphology predict 1p/19q loss in oligodendroglial tumours? Scheie D; Cvancarova M; Mørk S; Skullerud K; Andresen PA; Benestad I; Helseth E; Meling T; Beiske K Histopathology; 2008 Nov; 53(5):578-87. PubMed ID: 18983467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]